Abstract:OBJECTIVETo evaluate the effects of oral appliance (OA) treatment upon systemic blood pressure (BP) in mild to moderate patients with obstructive sleep apnea-hypopnea syndrome (OSAHS).METHODSForty-six consecutive patients diagnosed with OSAHS on polysomnography were divided into OA treatment group (OA group, 25 patients, 15 patients with hypertension) and non-tolerated OA treatment group (N-OA group, 21 patients, 13 patients with hypertension). Polysomnography and 24-hour ambulatory blood pressure monitoring (ABPM) were performed at baseline in two groups. Polysomnography and ABPM were repeated after a completion of 12 weeks of treatment in OA group and after a cessation of treatment for 12 weeks in N-OA group. Hypertensive patients in two groups continued taking the same kind and the same dose of antihypertensive agents during the period of study.RESULTSThere was no significant difference between the two groups in age, body mass index, Epworth sleepiness score (ESS), apnoea-hypopnoea index (AHI), arousal index (AI) and minimum arterial oxygen saturation (MSaO2) at baseline. After a 12-week treatment, OA group showed significant improvement in AHI [(7.0 +/- 3.8) vs (21.0 +/- 6.5) per hour, P < 0.01], AI [(22.9 +/- 6.3) vs (32.2 +/- 9.3) per hour, P < 0.01] and MSaO2 (86.8% +/- 3.5% vs 80.0% +/- 5.2%, P < 0.01), while nocturnal mean systolic blood pressure (SBP) and diastolic blood pressure (DBP), 24-hour and diurnal SBP, and nocturnal mean artery pressure (MAP) were significantly reduced [(121.3 +/- 7.0) vs (125.3 +/- 9.3), (76.1 +/- 6.1) vs (78.8 +/- 6.8), (127.2 +/- 7.5) vs (129.4 +/- 8.8), (131.5 +/- 6.9) vs (133.6 +/- 8.1), and (91.2 +/- 6.4) vs (94.3 +/- 7.6) mm Hg respectively, all P < 0.01]. The reduction in nocturnal MAP was significantly correlated to improvement in AI(r = 0.37, P = 0.005) and AHI (r = 0.32, P = 0.011), to baseline nocturnal mean blood pressure (SBP: r = 0.39, P = 0.015; DBP: r = 0.30, P = 0.024). The N-OA group showed no differences in blood pressure variables between baseline and after a cessation of treatment for 12 weeks.CONCLUSIONOral appliance treatment for mild to moderate OSAHS may lead to a reduction in systemic blood pressure.

Meta-analysis: the efficacy of continuous positive airway pressure therapy on blood pressure in obstructive sleep apnea hypopnea syndrom patients

Continuous positive airway pressure for treating high blood pressure of patients with obstructive sleep apnea-hypopnea syndrome：a meta-analysis

Effects of Continuous Positive Airway Pressure on Blood Pressure in Patients with Resistant Hypertension and Obstructive Sleep Apnea: a Systematic Review and Meta-Analysis of Six Randomized Controlled Trials

Effect of Continuous Positive Airway Pressure on Blood Pressure in Patients with Resistant Hypertension and Obstructive Sleep Apnea: An Updated Meta-analysis

Beneficial Response of Blood Pressure to Short-Term Continuous Positive Airway Pressure in Chinese Patients with Obstructive Sleep Apnea-Hypopnea Syndrome.

Comprehensive curative effect of CPAP combined with conventional antihypertensive drugs on OSAHS patients with hypertension based on Meta-analysis

Analysis of the improvement of quality of life in patients with obstructive sleep apnea hypopnea syndromes associated hypertension with continuous positive airway pressure

Effect of continuous positive airway pressure therapy on blood pressure variability of obstructive sleep apnea hypopnea syndrome

Effect of Continuous Positive Airway Pressure on Cardiometabolic Risk Factors in Patients with Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis

[Impact of Long-Term Continuous Positive Airway Pressure Treatment for Patients with Obstructive Sleep Apnea Syndrome].

Study on 24H-Blood Pressure Variability in Patients of Obstructive Sleep Apnea with Continuous Positive Airway Pressure Therapy

A randomized controlled trial on ambulatory blood pressure lowering effect of CPAP in patients with obstructive sleep apnea and nocturnal hypertension

Effects of Continuous Positive Airway Pressure on C-reactive Protein and Interleukin-6 in Obstructive Sleep Apnea-hypopnea Syndrome with Hypertension

Study on pressure level of continuous positive airway pressure in the treatment of obstructive sleep apnea hypoxia syndrome

Influence of Continuous Positive Airway Pressure Treatment on Cardiovascular Risk Factors in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Analysis of the Relationship of Obstructive Sleep Apnea Syndrome with Hypertension

Continuous positive airway pressure adherence and blood pressure lowering in patients with obstructive sleep apnoea syndrome and nocturnal hypertension

CPAP effects on blood pressure in different OSA phenotypes - a meta-analysis

Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients

E ectiveness of Oral Appliance versus Continuous Positive Airway Pressure in Treating Patients with Mild to Moderate Obstructive Sleep Apnea-Hypopnea Syndrome: A Meta-Analysis

[Effects of Oral Appliance Treatment Upon Blood Pressure in Mild to Moderate Obstructive Sleep Apnea-Hypopnea Syndrome].